Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,526 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy.
Joerger M, Huitema AD, Boot H, Cats A, Doodeman VD, Smits PH, Vainchtein L, Rosing H, Meijerman I, Zueger M, Meulendijks D, Cerny TD, Beijnen JH, Schellens JH. Joerger M, et al. Among authors: beijnen jh. Cancer Chemother Pharmacol. 2015 Apr;75(4):763-72. doi: 10.1007/s00280-015-2698-7. Epub 2015 Feb 13. Cancer Chemother Pharmacol. 2015. PMID: 25677447
Limited sampling models for topotecan pharmacokinetics.
van Warmerdam LJ, Verweij J, Rosing H, Schellens JH, Maes RA, Beijnen JH. van Warmerdam LJ, et al. Among authors: beijnen jh. Ann Oncol. 1994 Mar;5(3):259-64. doi: 10.1093/oxfordjournals.annonc.a058804. Ann Oncol. 1994. PMID: 8186175 Free article.
Pharmacokinetics and pharmacodynamics of topotecan given on a daily-times-five schedule in phase II clinical trials using a limited-sampling procedure.
van Warmerdam LJ, Creemers GJ, Rodenhuis S, Rosing H, de Boer-Dennert M, Schellens JH, ten Bokkel Huinink WW, Davies BE, Maes RA, Verweij J, Beijnen JH. van Warmerdam LJ, et al. Among authors: beijnen jh. Cancer Chemother Pharmacol. 1996;38(3):254-60. doi: 10.1007/s002800050479. Cancer Chemother Pharmacol. 1996. PMID: 8646800 Clinical Trial.
Pharmacokinetics of paclitaxel and three major metabolites in patients with advanced breast carcinoma refractory to anthracycline therapy treated with a 3-hour paclitaxel infusion: a European Cancer Centre (ECC) trial.
Huizing MT, Vermorken JB, Rosing H, ten Bokkel Huinink WW, Mandjes I, Pinedo HM, Beijnen JH. Huizing MT, et al. Among authors: beijnen jh. Ann Oncol. 1995 Sep;6(7):699-704. doi: 10.1093/oxfordjournals.annonc.a059287. Ann Oncol. 1995. PMID: 8664192 Free article. Clinical Trial.
1,526 results